 |
Bayern Innovativ
eLetter Network Life Science |
November 2009 | |
 |
Welcome to the Network Life Science eLetter. The current eLetter covers, amongst other topics, novel technologies for drug development and aspects regarding the market success of innovative drug candidates. These topics will be the focus of upcoming events of the Network Life Science.
Please click on the links in the articles to obtain further information.
|
|
|
|
Drug Development 2009: Strategies – Technologies – Therapies
Successful drug development is the basis for innovative products and therapies brought rapidly to the market and the patient. Experts from pharma and biotech industry as well as academia will present at the Cooperation Forum 'Drug Development' on 3 December 2009 in Würzburg strategies for research co-operation and novel technology platforms for drug development with focus on oncology and infectious diseases. Major topics are e.g. personalised medicine, pharmacogenomics, molecular diagnostics, oligonucleotid-based therapeutics, chemical proteomics, drug safety and translational research.
Top research versus market obstacles for innovative products
Chances of novel drugs in respect to tightening reimbursement schemes of health care providers are the focus of the panel discussion on 2 December 2009 in Würzburg.
Review: Cooperation Forum 'Functional Plant-derived Ingredients'
Bayern Innovativ conceptualised and organised within the Network Life Science for the first time the cooperation forum 'Functional Plant-derived Ingredients – Food, Pharma, Cosmetics'. One focus was on hop ingredients. Therefore, the forum took place on 1 October 2009 at the German Hop Museum in Wolnzach. This town is in the middle of the Hallertau - a region generating more than one third of the worldwide hop production. With 210 participants from Germany, Austria and Switzerland, this first forum was a resounding success. It was a meeting point for experts from companies and institutes along the value chain - plant breeding, plant production, processing and hightech analysis regarding the functionality and application of value-added products in food, pharma and cosmetics.
b3c newswire offers access to Web 2.0 PR technologies to optimize news visibility
The steadily growing impact of the Internet necessitates the implementation of online-PR strategies in addition to targeting the well-known trade magazines. For PR departments that are not yet ready for 'Biotech 2.0' b3c newswire offers access to Web 2.0 PR technologies.
Events
|
InnovAsia 2009: Food in the Future
17.12.2009 - 19.12.2009, Bangkok, Thailand
The international conference and exhibition on food innovation provides an excellent opportunity to meet with potential technology partners from Thailand and Southeast Asia in the fields of food, agro as well as plant-derived ingredients. Bayern Innovativ collaborates with NIA, the organiser of InnovAsia 2009.
|
|
1st Metabolomics Symposium in Germany
Metabolomics & More
The Impact of Metabolomics on the Life Sciences
10.03.2010 - 12.03.2010, Technische Universität München, Freising-Weihenstephan
The conference will focus on new analytic methods, late-breaking discoveries, as well as challenges and pitfalls in metabolomics studies. Leading scientists will discuss the value of Metabolomics in basic science applications, in diagnostics and in nutrition and food research.
|
Imprint
The Network Life Science eLetter is published by Bayern Innovativ GmbH Gewerbemuseumsplatz 2 90403 Nuremberg Germany Tel. +49 911-20671-0 Fax +49 911-20671-792 http://www.bayern-innovativ.delifescience@bayern-innovativ.deFor your subscription, your email address is required. You may of course use an anonymous email address from a free mailer. To subscribe or to unsubscribe, please go to the eLetter Webpage of the Network Life Science http://www.lifescience.de/eletter For further questions, please contact lifescience@bayern-innovativ.deChief Executive Bayern Innovativ GmbH: Prof. Dr.-Ing. habil. Josef Nassauer Chairman of the Supervisory Board: Martin Zeil, Bavarian State Minister for Economic Affairs, Infrastructure, Transport and Technology Registered Office: Nuremberg, HRB 13 224 | |
